| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84854097A | 1997-04-28 | 1997-04-28 | |
| US08848540 | 1997-04-28 | ||
| PCT/US1998/008484WO1998048790A1 (en) | 1997-04-28 | 1998-04-28 | Use of genistein and related compounds to treat certain sex hormone related conditions |
| Publication Number | Publication Date |
|---|---|
| AU7165798Atrue AU7165798A (en) | 1998-11-24 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU71657/98AAbandonedAU7165798A (en) | 1997-04-28 | 1998-04-28 | Use of genistein and related compounds to treat certain sex hormone related conditions |
| Country | Link |
|---|---|
| AU (1) | AU7165798A (en) |
| WO (1) | WO1998048790A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT656786E (en) | 1992-05-19 | 2004-11-30 | Novogen Res Pty Ltd | USE OF PHYSIESTROGENIC EXTRACTS OF SOYBEAN ISOFLAVONE OR CLOVER |
| AUPO203996A0 (en) | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| US6146668A (en) | 1997-04-28 | 2000-11-14 | Novogen, Inc. | Preparation of isoflavones from legumes |
| EP1027045A4 (en)* | 1997-10-31 | 2004-12-08 | Arch Dev Corp | METHODS AND COMPOSITIONS FOR REGULATING 5-ALPHA-REDUCTASE ACTIVITY |
| US5958946A (en)* | 1998-01-20 | 1999-09-28 | Styczynski; Peter | Modulation of hair growth |
| AUPP260798A0 (en) | 1998-03-26 | 1998-04-23 | Novogen Research Pty Ltd | Treatment of medical related conditions with isoflavone containing extracts of clover |
| EP1137427A1 (en) | 1998-12-07 | 2001-10-04 | Ecosmart Technologies Inc. | Cancer treatment composition and method using natural plant essential oils with signal transduction modulators |
| AUPQ266199A0 (en)* | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
| GB2361642A (en)* | 2000-10-24 | 2001-10-31 | Karobio Ab | Estrogen receptor beta (ERbeta) agonists for use in cancer treatment |
| AUPR363301A0 (en) | 2001-03-08 | 2001-04-05 | Novogen Research Pty Ltd | Dimeric isoflavones |
| PL205635B1 (en)* | 2001-04-09 | 2010-05-31 | Inst Farmaceutyczny | Novel derivatives of genistein and pharmacological agents containing such derivatives |
| SE0101697D0 (en)* | 2001-05-14 | 2001-05-14 | Astrazeneca Ab | Pharmaceutical combination |
| ATE361746T1 (en)* | 2002-03-06 | 2007-06-15 | Medical Res And Education Trus | BOTANICAL EXTRACT WITH ANTI-CANCER ACTIVITY CONTAINING ISOLIQUIRITIGENIN |
| EP1808172A3 (en)* | 2002-03-06 | 2010-05-26 | Activephyto Technologies Limited | Botanical extract compositions and methods of use |
| US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
| AU2003259220C1 (en) | 2002-07-24 | 2017-08-24 | Australian Health & Nutrition Association Limited | Compositions and products containing enantiomeric equol, and methods for their making |
| JP4889944B2 (en) | 2002-10-29 | 2012-03-07 | コロラド ステート ユニバーシティー リサーチ ファウンデーション | Use of equol to treat androgen-mediated diseases |
| US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
| US8680140B2 (en)* | 2006-08-02 | 2014-03-25 | University Of Southern California | Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms |
| TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
| US8221803B1 (en) | 2007-06-25 | 2012-07-17 | OncoNatural Solutions, Inc. | Composition for prostate health |
| WO2009026657A1 (en)* | 2007-08-29 | 2009-03-05 | The University Of Sydney | Flavonoid ppar agonists |
| WO2009049214A2 (en)* | 2007-10-12 | 2009-04-16 | Northwestern University | Inhibition and treatment of prostate cancer metastasis |
| TWI472525B (en) | 2008-12-05 | 2015-02-11 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
| CN113214211B (en)* | 2021-04-23 | 2022-04-22 | 广东药科大学 | Compound extracted from peony bark charcoal and preparation method and pharmaceutical application thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61246124A (en)* | 1985-04-24 | 1986-11-01 | Yamanouchi Pharmaceut Co Ltd | Carcinostatic agent |
| JPH0196124A (en)* | 1987-10-07 | 1989-04-14 | Fujirebio Inc | anticancer drug |
| JPH085788B2 (en)* | 1987-10-08 | 1996-01-24 | 花王株式会社 | 5α-reductase inhibitor |
| PT656786E (en)* | 1992-05-19 | 2004-11-30 | Novogen Res Pty Ltd | USE OF PHYSIESTROGENIC EXTRACTS OF SOYBEAN ISOFLAVONE OR CLOVER |
| US5911995A (en)* | 1994-08-19 | 1999-06-15 | Regents Of The University Of Minnesota | EGF-genistein conjugates for the treatment of cancer |
| US5587459A (en)* | 1994-08-19 | 1996-12-24 | Regents Of The University Of Minnesota | Immunoconjugates comprising tyrosine kinase inhibitors |
| DE4432947C2 (en)* | 1994-09-16 | 1998-04-09 | New Standard Gmbh | Agent for the treatment of the skin and its use |
| AU5970496A (en)* | 1995-06-07 | 1996-12-30 | Patrick C. Kung | Compounds and methods for promoting hair growth |
| AUPO203996A0 (en)* | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| Publication number | Publication date |
|---|---|
| WO1998048790A1 (en) | 1998-11-05 |
| Publication | Publication Date | Title |
|---|---|---|
| AU7165798A (en) | Use of genistein and related compounds to treat certain sex hormone related conditions | |
| IL116479A0 (en) | Antifungal compositions and bandage for treatment of nails | |
| AU1721697A (en) | Use of compositions comprising stabilized biologically effective compounds | |
| GB0015235D0 (en) | Compositions for the treatment of skin and anorectal conditions | |
| PT1073416E (en) | Use of inhaled no as anti-inflammatory agent | |
| AU3684895A (en) | Use of human chorionic gonadotropin as an immune-potentiating agent | |
| ZA975267B (en) | Preparation of fungicidal quinazolinones and useful intermediates | |
| AU1773600A (en) | Topical treatment of skin disease | |
| AU5083098A (en) | Use of leptin to stimulate hematopoiesis | |
| PL336760A1 (en) | Treatment of skin diseases | |
| AU4945297A (en) | Pyrazolinones to treat disturbances of potency | |
| EP1011689B8 (en) | USE OF 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS | |
| AU2003204844A1 (en) | Use of methylnaltrexone and related compounds | |
| AU1295099A (en) | Water repellent restorative and process of use | |
| AU1228499A (en) | Application of tnf antagonists as medicaments for treating septic diseases | |
| AU9756898A (en) | Human prostaglandin receptors and methods of use thereof | |
| AU7647798A (en) | Preparation of mibefradil i | |
| AU4759397A (en) | Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents | |
| ZA989514B (en) | Treatment of diabetic retinopathy | |
| ZA97253B (en) | Topical compositions for the treatment of skin diseases | |
| AU4308699A (en) | Use of anti-prolactin agents to treat proliferative conditions | |
| IL136342A0 (en) | Formulation for topical treatment of skin infections | |
| ID24439A (en) | USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT | |
| GB2324962B (en) | Treatment of allergic conditions | |
| GB9709451D0 (en) | Treatment of allergic conditions |
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |